Medical insurance and medical linkage under the "zero plus" of drug exploration by medical people

[forum of China Pharmaceutical network] at present, Medicare drugs account for about 60% of China's drug market At the 2017 China pharmaceutical trade annual meeting, leading experts from the national health and Family Planning Commission and relevant functional departments of Guangdong Province interpreted the new policies of medical insurance system reform, such as the multi-component medical insurance payment method based on the payment of drugs and medical consumables by disease, for medical industry practitioners from all over the country The 2017 China pharmaceutical trade annual meeting ended in Guangzhou on the 24th The annual meeting was hosted by Guangdong drug trade center During the two-day meeting, medical industry practitioners from all over the country focused on the theme of "sharing, symbiosis, win-win -- medical insurance and medical linkage to help health China", and jointly discussed the medical insurance and medical linkage under the "zero plus" of drugs The 2017 Blue Book of Guangdong's pharmaceutical development was released on the site of the annual meeting, which comprehensively evaluated the current level of Guangdong's pharmaceutical development and the future industrial growth momentum through four aspects: the general introduction of macro policies, the pattern and supervision implementation of Guangdong's pharmaceutical trading market, the reform trend of medical services and medical security, and the innovation, transformation and upgrading trend of pharmaceutical enterprises, and put forward decision-making suggestions At the meeting, the "2017 Guangdong drug trade big data perspective" and "2017 Guangdong drug trade price index" were also released According to the report, since the implementation of the new drug trading method in 2017, the total amount of bidding transactions of medical institutions at all levels in Guangdong Province has slightly decreased, and the amount of bargaining transactions has increased significantly It is predicted that the turnover of medical insurance drugs will exceed 100 billion yuan in 2017 At present, medical insurance drugs account for about 60% of China's drug market At the annual meeting, leaders and experts from the national health and Family Planning Commission and relevant functional departments of Guangdong Province interpreted the new policies of medical insurance system reform, such as the multi-component payment method of medical insurance based on the payment of drugs and medical consumables by disease, for medical industry practitioners from all over the country As a big purchaser of drug market, medical insurance fund has become a big variable to determine the growth rate of drug industry Lai Shiqing, the Department of health and family planning reform of the State Council and the state health and Family Planning Commission, said that the state comprehensively implemented the "payment by disease" mode of medical insurance, so as to reduce the phenomenon of excessive medical treatment and blind introduction of medical equipment and technology, so as to fully release the momentum of cost control of medical insurance In the era of "zero difference rate" of drugs, hospitals should adjust the cost management mode and change from scale expansion to connotation type, so as to ensure the sound development of hospital operation and the steady improvement of medical service level In addition, the implementation of medical insurance payment price limit, and the coordination of medical insurance funds and drug procurement are also the Exploration Trend of the future joint reform of medical insurance and medicine Original title: medical insurance and medical linkage under "zero plus" of drugs reporter: Jing Huaiqiao